Subscribe to our newsletter

Dr. Hidalgo has served as chief of the division of hematology and medical oncology at Weill Cornell Medicine/New York-Presbyterian Hospital since 2019 and is responsible for leading clinical and translational research in hematology, vascular biology and oncology. He is also the E. Hugh Luckey distinguished professor of medicine and associate director for clinical services at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. Dr. Hidalgo is currently serving on the board of Bristol-Myers Squibb.

Dr. Hidalgo brings to the Board more than 20 years of experience in translational and clinical research in anticancer drug development, with an emphasis in gastrointestinal cancers. He has also led the early clinical development of new anticancer agents for pancreatic cancer among other solid tumor cancers.

Prior to his current position, Dr. Hidalgo served as chief of the division of hematology at Beth Israel Deaconess Medical Center in Boston and clinical director of the Rosenberg Clinical Cancer Center from 2015 to 2019. During this time, he was the Theodore W. and Evelyn G. Berenson professor of medicine at Harvard Medical School. Dr. Hidalgo also held leadership positions at the Spanish National Cancer Research Centre (CNIO) in Madrid and at the Kimmel Comprehensive Cancer Center, where he was director of gastrointestinal oncology program.